{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,10]],"date-time":"2024-09-10T04:39:34Z","timestamp":1725943174628},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2004,12,1]],"date-time":"2004-12-01T00:00:00Z","timestamp":1101859200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Seminars in Oncology"],"published-print":{"date-parts":[[2004,12]]},"DOI":"10.1053\/j.seminoncol.2005.02.001","type":"journal-article","created":{"date-parts":[[2005,11,3]],"date-time":"2005-11-03T08:58:14Z","timestamp":1131008294000},"page":"2-7","source":"Crossref","is-referenced-by-count":24,"special_numbering":"S18","title":["The evaluation of amifostine for mucosal protection in patients with advanced loco-regional Squamous Cell Carcinomas of the Head and Neck (SCCHN) treated with concurrent weekly carboplatin, paclitaxel, and daily Radiotherapy (RT)"],"prefix":"10.1053","volume":"31","author":[{"given":"Mohan","family":"Suntharalingam","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jerry","family":"Jaboin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rodney","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey","family":"Wolf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Madan","family":"Banglore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Van Echo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Ord","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1053\/j.seminoncol.2005.02.001_bib1","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1002\/1097-0142(19870115)59:2<259::AID-CNCR2820590214>3.0.CO;2-1","article-title":"Concurrent radiotherapy and chemotherapy with cisplatin in inoperable squamous cell carcinoma of the head and neck. An RTOG Study","volume":"59","author":"Al-Sarraf","year":"1987","journal-title":"Cancer"},{"key":"10.1053\/j.seminoncol.2005.02.001_bib2","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/oxfordjournals.annonc.a010467","article-title":"Chemotherapy of squamous cell carcinoma of head and neck","volume":"7","author":"Vokes","year":"1996","journal-title":"Ann Oncol"},{"key":"10.1053\/j.seminoncol.2005.02.001_bib3","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/S0140-6736(00)90011-0","article-title":"Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: Three meta-analyses of updated individual data. MACH-NC Collaborative Group. Meta-Analysis of Chemotherapy on Head and Neck Cancer","volume":"355","author":"Pignon","year":"2000","journal-title":"Lancet"},{"key":"10.1053\/j.seminoncol.2005.02.001_bib4","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1080\/095530098142220","article-title":"Altered fractionation in the management of head and neck cancer","volume":"73","author":"Ang","year":"1998","journal-title":"Int J Radiat Biol"},{"key":"10.1053\/j.seminoncol.2005.02.001_bib5","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1093\/jnci\/88.13.890","article-title":"Larynx preservation in pyriform sinus cancer","volume":"88","author":"Lefebvre","year":"1996","journal-title":"J Natl Cancer Inst"},{"key":"10.1053\/j.seminoncol.2005.02.001_bib6","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1200\/JCO.1998.16.4.1310","article-title":"Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer","volume":"16","author":"Al-Sarraf","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.seminoncol.2005.02.001_bib7","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1200\/JCO.1999.17.2.638","article-title":"Radiation therapy with concomitant hydroxyurea and fluorouracil in stage II and III head and neck cancer","volume":"17","author":"Haraf","year":"1999","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.seminoncol.2005.02.001_bib8","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s11912-001-0044-1","article-title":"Treatment of advanced head and neck cancer with intra-arterial cisplatin and concurrent radiation therapy","volume":"3","author":"Kumar","year":"2001","journal-title":"Curr Oncol Rep"},{"key":"10.1053\/j.seminoncol.2005.02.001_bib9","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1200\/JCO.1998.16.4.1318","article-title":"Simultaneous radiochemotherapy versus radiotherapy alone in advanced head and neck cancer","volume":"16","author":"Wendt","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.seminoncol.2005.02.001_bib10","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0360-3016(00)00408-9","article-title":"The use of carboplatin and paclitaxel with daily radiotherapy in patients with locally advanced squamous cell carcinomas of the head and neck","volume":"47","author":"Suntharalingam","year":"2000","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"suppl 1","key":"10.1053\/j.seminoncol.2005.02.001_bib11","doi-asserted-by":"crossref","first-page":"S8","DOI":"10.1016\/0959-8049(95)00144-8","article-title":"Protection of normal tissue from the cytotoxic effects of chemotherapy and radiation by amifostine","volume":"31A","author":"Capizzi","year":"1995","journal-title":"Eur J Cancer"},{"key":"10.1053\/j.seminoncol.2005.02.001_bib12","first-page":"425","article-title":"Chemoprotective and radioprotective effects of amifostine","volume":"72","author":"Capizzi","year":"2000","journal-title":"Int J Hematol"},{"key":"10.1053\/j.seminoncol.2005.02.001_bib13","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1016\/S0959-8049(97)00221-9","article-title":"Amifostine protects normal tissues from paclitaxel toxicity while cytotoxicity against tumour cells is maintained","volume":"33","author":"Taylor","year":"1997","journal-title":"Eur J Cancer"},{"key":"10.1053\/j.seminoncol.2005.02.001_bib14","first-page":"2","article-title":"Amifostine","volume":"23","author":"Capizzi","year":"1996","journal-title":"Semin Oncol"},{"key":"10.1053\/j.seminoncol.2005.02.001_bib15","first-page":"58","article-title":"Chemoradiotherapy for advanced inoperable head and neck cancer","volume":"9","author":"Chougule","year":"1999","journal-title":"Semin Radiat Oncol"},{"key":"10.1053\/j.seminoncol.2005.02.001_bib16","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1056\/NEJM199806183382503","article-title":"Hyperfractionated irradiation with or without concurrent chemotherapy for locally advanced head and neck cancer","volume":"338","author":"Brizel","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1053\/j.seminoncol.2005.02.001_bib17","doi-asserted-by":"crossref","first-page":"3333","DOI":"10.1200\/JCO.2001.19.14.3333","article-title":"High-dose intra-arterial cisplatin boost with hyperfractionated radiation therapy for advanced squamous cell carcinoma of the head and neck","volume":"19","author":"Regine","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.seminoncol.2005.02.001_bib18","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/S0889-8588(05)70091-5","article-title":"Meta-analyses in head and neck squamous cell carcinoma. What is the role of chemotherapy?","volume":"13","author":"Bourhis","year":"1999","journal-title":"Hematol Oncol Clin North Am"},{"issue":"suppl A","key":"10.1053\/j.seminoncol.2005.02.001_bib19","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/0305-7372(85)90026-X","article-title":"Carboplatin as a potentiator of radiation therapy","volume":"12","author":"Douple","year":"1985","journal-title":"Cancer Treat Rev"},{"key":"10.1053\/j.seminoncol.2005.02.001_bib20","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S0924-4212(97)86084-7","article-title":"Concomitant radiotherapy and chemotherapy in the treatment of cancers of the upper respiratory and digestive tracts","volume":"83","author":"Calais","year":"1996","journal-title":"Bull Cancer Radiother"},{"key":"10.1053\/j.seminoncol.2005.02.001_bib21","first-page":"223","article-title":"Preliminary results of RTOG 9703-A phase II randomized trial of concurrent radiation (RT) and chemotherapy for advanced squamous cell carcinomas of the head and neck","volume":"20","author":"Garden","year":"2001","journal-title":"Proc Am Soc Clin Oncol"},{"key":"10.1053\/j.seminoncol.2005.02.001_bib22","first-page":"495","article-title":"The influence of intravenous amifostine on xerostomia and survival during radiotherapy for head and neck cancer","volume":"23","author":"Brizel","year":"2004","journal-title":"Proc Am Soc Clin Oncol"},{"key":"10.1053\/j.seminoncol.2005.02.001_bib23","doi-asserted-by":"crossref","first-page":"3339","DOI":"10.1200\/JCO.2000.18.19.3339","article-title":"Phase III randomized trial of amifostine as a radioprotector in head and neck cancer","volume":"18","author":"Brizel","year":"2000","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.seminoncol.2005.02.001_bib24","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1053\/srao.2002.31358","article-title":"A phase II trial of subcutaneous amifostine and radiation therapy in patients with head and neck cancer","volume":"12","author":"Anne","year":"2002","journal-title":"Semin Radiat Oncol"},{"key":"10.1053\/j.seminoncol.2005.02.001_bib25","doi-asserted-by":"crossref","first-page":"2226","DOI":"10.1200\/JCO.2000.18.11.2226","article-title":"Subcutaneous administration of amifostine during fractionated radiotherapy","volume":"18","author":"Koukourakis","year":"2000","journal-title":"J Clin Oncol"}],"container-title":["Seminars in Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0093775405000564?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0093775405000564?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,4]],"date-time":"2019-04-04T00:27:32Z","timestamp":1554337652000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0093775405000564"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,12]]},"references-count":25,"alternative-id":["S0093775405000564"],"URL":"https:\/\/doi.org\/10.1053\/j.seminoncol.2005.02.001","relation":{},"ISSN":["0093-7754"],"issn-type":[{"value":"0093-7754","type":"print"}],"subject":[],"published":{"date-parts":[[2004,12]]}}}